pharmaceutical companies news from FierceHealthcare
News
MA drops planned ban on physician gifts from drugmakers
Massachusetts legislators have stripped several controversial provisions out of pending legislation which would have imposed strict new rules on pharmaceutical company relationships with doctors. Read more...
Psychiatric group's drugmaker ties questioned
Under attack from Congress, particularly Sen. Charles Grassley (R-IA), the psychiatric field's leading professional organization is being forced to explain its tight financial relationships with the Read more...
Pharmas adopt voluntary marketing guidelines banning doctor gifts
Taking control of what may have otherwise been forced upon it, the pharmaceutical industry has agreed to a voluntary code of conduct which bans gifts to physicians. The rules, the Code on Read more...
AstraZeneca asks judge to nullify $215M drug-price lawsuit
Drugmaker AstraZeneca has asked an Alabama judge to nullify a jury verdict that ordered it to pay the state $215 million in damages in a Medicaid drug-price fraud suit. The state's 2005 suit accused Read more...
Harvard psychiatrists fail to reveal millions in pharma pay
A Harvard child psychiatrist with a global reputation whose work has helped to promote the use of antipsychotic meds in children apparently didn't report most of the $1.6 million in drug maker Read more...
Walgreens agrees to $35M drug-switching settlement
Walgreen Co. has agreed to pay $35 million to the U.S. Department of Justice to resolve allegations that it had switched patients to more expensive drugs to boost its Medicaid reimbursement. In the Read more...
Few drugs being developed for pregnant women
While the subject isn't discussed much, it's an open secret that there are few drugs that serve the health needs of the 4 million American women who give birth each year. In fact, in many cases Read more...
Personalized cancer treatment on the rise, cutting drug spend
If research presented at this year's annual meeting of the American Society of Clinical Oncology is any indication, the time could arrive sooner than expected for "personalized medicine," in which Read more...
CT sues McKesson for allegedly inflating drug prices
The Connecticut attorney general's office is suing pharmaceutical distributor McKesson Corp., contending that it's been illegally inflating the average wholesale price of more than 400 brand-name Read more...
CA bill would let pharmacies sell patient prescription data
A new California bill working its way through the state Senate would allow pharmacies there to sell patient prescription information to third-party marketing firms working for pharmaceutical Read more...
Get more pharmaceutical companies coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies